InvestorsHub Logo
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Re: None

Thursday, 10/05/2017 8:58:15 AM

Thursday, October 05, 2017 8:58:15 AM

Post# of 40492
Inovio = the new Glaxo!

http://www.nejm.org/doi/full/10.1056/NEJMoa1708120#t=articleTop


Inovio’s Positive Zika Vaccine Clinical Study Data Published in New England Journal of Medicine
Date : 10/05/2017 @ 7:00AM
Source : GlobeNewswire Inc.
Stock : Inovio Pharmaceuticals, Inc. (MM) (INO)
Quote : 6.48 0.0 (0.00%) @ 8:38AM

Inovio’s Positive Zika Vaccine Clinical Study Data Published in New England Journal of Medicine

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) reported today on positive safety and immune response results from a first-in-man, multi-center phase 1 trial of a vaccine against the Zika virus. The phase 1 trial of Inovio’s DNA-based Zika vaccine (GLS-5700) induced high levels of binding antibodies in 100% of participants. Robust neutralizing antibody and T cell immune response were also observed in vaccinated subjects. These positive results appear in the New England Journal of Medicine in the article: “Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine,” by Inovio researchers and collaborators.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News